Post-Registration projects
Discovery and Preclinical Projects
Business development
clinical Projects
DNDi's Activities Worldwide
fundraising AND ADVOCACY
Four Characteristics For Partnership

SCYNEXIS has established a successful record centred around:

  1. Expertise in the demonstration of lead optimisation to clinical candidates.
  2. A track record of innovative drugs delivered to the industry (Big Pharma and Biotech).
  3. Knowledge of anti-infective and anti-parasitic drug discovery and development.
  4. A history of and commitment to working with organisations such as MMV and TDR along with a good understanding of the challenges facing drug development for Neglected Diseases.

SCYNEXIS' expertise, knowledge, history, and track record make it a good partner to pursue new, effective medicines with DNDi's financial and late development support. We are confident that the commitment that our two organisations have focused on this great need will lead us to successfully respond to the challenges of Neglected Diseases.

Published by Drugs for Neglected Diseases Initiative - 15 Chemin Louis-Dunant 1202 Geneva Switzerland - Photo credits: DNDi unless otherwise stated - Editor: Sadia Kaenzig - Tel: +41 22 906 9230 - Fax: +41 22 906 9231 -